115 related articles for article (PubMed ID: 15007140)
1. Association of APOE polymorphisms with disease severity in MS is limited to women.
Kantarci OH; Hebrink DD; Achenbach SJ; Pittock SJ; Altintas A; Schaefer-Klein JL; Atkinson EJ; De Andrade M; McMurray CT; Rodriguez M; Weinshenker BG
Neurology; 2004 Mar; 62(5):811-4. PubMed ID: 15007140
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
[TBL] [Abstract][Full Text] [Related]
4. Association of apolipoprotein E genotypes with prognosis in multiple sclerosis.
Tamam Y; Tasdemir N; Yalman M; Tamam B
Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1122-30. PubMed ID: 22165672
[TBL] [Abstract][Full Text] [Related]
5. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
6. Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects.
Yin YW; Zhang YD; Wang JZ; Li BH; Yang QW; Fang CQ; Gao CY; Li JC; Zhang LL
Gene; 2012 Dec; 511(1):12-7. PubMed ID: 22982410
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment in patients with multiple sclerosis: association with the APOE gene and promoter polymorphisms.
Parmenter BA; Denney DR; Lynch SG; Middleton LS; Harlan LM
Mult Scler; 2007 Jan; 13(1):25-32. PubMed ID: 17294608
[TBL] [Abstract][Full Text] [Related]
8. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
[TBL] [Abstract][Full Text] [Related]
10. Association of the APOE epsilon4 allele with disease activity in multiple sclerosis.
Evangelou N; Jackson M; Beeson D; Palace J
J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):203-5. PubMed ID: 10406990
[TBL] [Abstract][Full Text] [Related]
11. Association of APOE polymorphisms with disease severity in MS is limited to women.
Zwemmer J; Uitdehaag B; van Kamp G; Barkhof F; Polman C
Neurology; 2004 Sep; 63(6):1139; author reply 1139. PubMed ID: 15452327
[No Abstract] [Full Text] [Related]
12. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients].
Corona T; Guerrero-Camacho JL; Alonso-Vilatela ME; Flores-Rivera Jde J
Rev Neurol; 2010 Jan 1-15; 50(1):19-22. PubMed ID: 20073019
[TBL] [Abstract][Full Text] [Related]
13. APOE genotypes and disease severity in multiple sclerosis.
Masterman T; Zhang Z; Hellgren D; Salter H; Anvret M; Lilius L; Lannfelt L; Hillert J
Mult Scler; 2002 Apr; 8(2):98-103. PubMed ID: 11990879
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis.
Fazekas F; Strasser-Fuchs S; Schmidt H; Enzinger C; Ropele S; Lechner A; Flooh E; Schmidt R; Hartung HP
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):25-8. PubMed ID: 10864599
[TBL] [Abstract][Full Text] [Related]
15. Interactions of functional apolipoprotein E gene promoter polymorphisms with smoking on aortic atherosclerosis.
Viiri LE; Viiri KM; Ilveskoski E; Huhtala H; Mäki M; Tienari PJ; Perola M; Lehtimäki T; Karhunen PJ
Circ Cardiovasc Genet; 2008 Dec; 1(2):107-16. PubMed ID: 20031552
[TBL] [Abstract][Full Text] [Related]
16. Involvement of apolipoprotein E in multiple sclerosis: absence of remyelination associated with possession of the APOE epsilon2 allele.
Carlin C; Murray L; Graham D; Doyle D; Nicoll J
J Neuropathol Exp Neurol; 2000 May; 59(5):361-7. PubMed ID: 10888365
[TBL] [Abstract][Full Text] [Related]
17. Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.
Enzinger C; Ropele S; Strasser-Fuchs S; Kapeller P; Schmidt H; Poltrum B; Schmidt R; Hartung HP; Fazekas F
Arch Neurol; 2003 Jan; 60(1):65-70. PubMed ID: 12533090
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E (APOE) phenotype and APOE concentrations in multiple sclerosis and acute herpes zoster.
Pirttilä T; Haanpää M; Mehta PD; Lehtimäki T
Acta Neurol Scand; 2000 Aug; 102(2):94-8. PubMed ID: 10949525
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis.
Fazekas F; Strasser-Fuchs S; Kollegger H; Berger T; Kristoferitsch W; Schmidt H; Enzinger C; Schiefermeier M; Schwarz C; Kornek B; Reindl M; Huber K; Grass R; Wimmer G; Vass K; Pfeiffer KH; Hartung HP; Schmidt R
Neurology; 2001 Sep; 57(5):853-7. PubMed ID: 11552016
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism interacts with cigarette smoking in progression of multiple sclerosis.
Sena A; Couderc R; Ferret-Sena V; Pedrosa R; Andrade ML; Araujo C; Roque R; Cascais MJ; Morais MG
Eur J Neurol; 2009 Jul; 16(7):832-7. PubMed ID: 19473356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
